Neurobiology and Genetics of Behavioural Syndromes of Alzheimer's Disease

McIlroy, Stephen; Craig, David
April 2004
Current Alzheimer Research;Apr2004, Vol. 1 Issue 2, p135
Academic Journal
The number of people with cognitive impairment is rising in parallel with changing demographics. As health care budgets are coming under increasing strain with regard to the provision of nursing care, there is a substantial need for effective therapies which encompass greater understanding of the components of dementia that finally necessitate admission to residential or nursing home care. Behavioural and psychological symptoms of dementia (BPSD) are major independent risk factors for admission to institutional care and research into the origin of BPSD is gathering pace. In this review, we evaluate the neurobiological and genetic changes described in individuals with BPSD in Alzheimer's disease. Particular emphasis is placed on genetic theories of causation, namely that BPSD results directly or indirectly from known genetic risk factors for AD, or distinct genetic risk factors for psychiatric illness assume clinical significance within the degenerated Alzheimer's brain.


Related Articles

  • Evolution of Specific Cognitive Subprofiles of Mild Cognitive Impairment in a Three-Year Longitudinal Study. Peraita, H.; Garc�a-Herranz, S.; D�az-Mardomingo, C. // Current Aging Science;Jul2011, Vol. 4 Issue 2, p171 

    The present work addresses one of the currently most controversial aspects of early detection of Alzheimer's disease (AD) and other dementias; that is, the identification of the Mild Cognitive Impairment (MCI) syndrome--in some cases, prior to AD--in a sample of older subjects who are healthy...

  • The Role of Functional Neuroimaging in Mild Cognitive Impairment. Marcos, Alberto; Barabash, Ana; Gil, Pedro; Encinas, Marta; De Juan, Ramón; Payno, María; Ancín, Inés; Vázquez, Blanca; Antonio Cabranes, José // Current Medical Imaging Reviews;2006, Vol. 2 Issue 2, p237 

    Mild Cognitive impairment (MCI) is a frequent problem in the elderly, since many of MCI subjects progress into Alzheimer's disease (AD). Recently new treatment options have been developed that may alter or delay the rate of AD deterioration. Wherefore, detecting and recognising patients that...

  • Memories are made of this: recent advances in understanding cognitive impairments and dementia. Banks, William A.; Morley, John E. // Journals of Gerontology Series A: Biological Sciences & Medical ;Apr2003, Vol. 58 Issue 4, p314 

    Discusses advances in understanding cognitive impairments and dementia. Information on Alzheimer's disease; Correlation between nutrition and dementia; Management of Alzheimer's disease.

  • Incidence of dementia and cognitive decline in over-75s in Cambridge: overview of cohort study. Paykel, E. S.; Huppert, F. A.; Brayne, C. // Social Psychiatry & Psychiatric Epidemiology;1998, Vol. 33 Issue 8, p387 

    This paper summarises the methods and some of the findings of a large cohort study of dementia and cognitive decline in subjects aged over 75 years in Cambridge, particularly regarding the incidence wave. From a sample of 1968 subjects previously studied in a prevalence study in 1985-1987,...

  • Genetic and Environmental Contributions to Cognitive Decline in Aging and Alzheimer's Disease. Welsh-Bohmer, Kathleen A.; Plassman, Brenda L.; Hayden, Kathleen M. // Annual Review of Gerontology & Geriatrics;2010, Vol. 30, p81 

    Inheritance appears to play a strong role in terms of human longevity and also in risk for chronic neurodegenerative diseases of late life such as Alzheimer's disease (AD). Understanding the role of genes in normal biological aging of the nervous system and in the expression of AD pathological...

  • Atrophy: When too much atrophy is too little brain. Romanowski, Charles; Wilkinson, Iain // Neuroradiology;Sep2011, Vol. 53, p133 

    The article discusses brain atrophy in the contexts of normal ageing and Alzheimer's disease (AD). The prevalence of AD and its possible connection with mild cognitive impairment (MCI) is mentioned. The discussion focuses on subtle changes that differentiate patients undergoing the normal...

  • Olfactory screening test in mild cognitive impairment. Eibenstein, A.; Fioretti, A. B.; Simaskou, M. N.; Sucapane, P.; Mearelli, S.; Mina, C.; Amabile, G.; Fusetti, M. // Neurological Sciences;Jul2005, Vol. 26 Issue 3, p156 

    Mild cognitive impairment (MCI) is a transient status between physiologic ageing and dementia. Each year more than 12% of subjects with MCI develop Alzheimer’s disease. This study evaluated the presence of an olfactory deficit in amnesic MCI (aMCI) patients. Twenty–nine patients...

  • Alzheimer's disease, Alzheimer disease.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p87 

    An encyclopedia entry for "Alzheimer's disease" which refers to a degenerative cognitive disorder is presented.

  • Mild cognitive impairment: pathology and mechanisms. Mufson, Elliott; Binder, Lester; Counts, Scott; DeKosky, Steven; deToledo-Morrell, Leyla; Ginsberg, Stephen; Ikonomovic, Milos; Perez, Sylvia; Scheff, Stephen // Acta Neuropathologica;Jan2012, Vol. 123 Issue 1, p13 

    Mild cognitive impairment (MCI) is rapidly becoming one of the most common clinical manifestations affecting the elderly. The pathologic and molecular substrate of people diagnosed with MCI is not well established. Since MCI is a human specific disorder and neither the clinical nor the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics